As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/14/24  Pacira BioSciences, Inc.          8-K:1,2,3,8  5/9/24   13:1.3M                                   Toppan Merrill/FA        
  5/8/24  Pacira BioSciences, Inc.          8-K:1,2,8,9  5/8/24   12:312K                                   Toppan Merrill/FA        
  5/7/24  Pacira BioSciences, Inc.          10-Q        3/31/24   86:8.3M                                                            
  5/7/24  Pacira BioSciences, Inc.          8-K:2,8,9    5/7/24   11:459K                                                            
 4/22/24  Pacira BioSciences, Inc.          ARS        12/31/23    1:3.1M                                   Toppan Merrill/FA        
 4/22/24  Pacira BioSciences, Inc.          DEFA14A                1:378K                                   Toppan Merrill/FA        
 4/22/24  Pacira BioSciences, Inc.          DEF 14A     6/11/24   11:17M                                    Toppan Merrill/FA        
  3/8/24  Pace Gary W                       4          Director²   1:7K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 
  3/6/24  Pace Gary W                       144                    1:12K  Pacira BioSciences, Inc.          Merri… Inc/Operations/FA 
 2/29/24  Pacira BioSciences, Inc.          S-8         2/29/24    4:108K                                                            
 2/29/24  Pacira BioSciences, Inc.          10-K       12/31/23  123:17M                                                             
 2/29/24  Pacira BioSciences, Inc.          8-K:2,5,7,9 2/26/24   11:567K                                                            
 2/13/24  Vanguard Group Inc.               SC 13G/A               1:13K  Pacira BioSciences, Inc.          Toppan Merrill/FA        
  2/7/24  Williams Kristen                  4          Officer²    1:5K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 
  2/7/24  Gaugler Daryl                     4          Officer²    1:5K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 
 1/19/24  BlackRock Inc.                    SC 13G/A               1:14K  Pacira BioSciences, Inc.          Blackrock Advisors LLC   
  1/4/24  Riker Lauren                      4          Officer²    1:5K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 
  1/4/24  Slonin Jonathan                   4          Officer²    1:7K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 
  1/4/24  Lee Frank D.                      4          Dir.,Off.²  1:6K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 
  1/4/24  Lee Frank D.                      3          Dir.,Off.²  2:9K   Pacira BioSciences, Inc.          Pacira BioSciences, Inc. 

____________
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.